Companion Animal Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030

Companion Animal Vaccine Trends and Forecast

The future of the global companion animal vaccine market looks promising with opportunities in the hospital & clinic and research institute markets. The global companion animal vaccine market is expected to reach an estimated $4.8 billion by 2030 with a CAGR of 6.3% from 2024 to 2030. The major drivers for this market are rising awareness about importance of pet vaccination, growing cases of zoonotic diseases, and increasing interest for pet ownership in the world.

A more than 150-page report is developed to help in your business decisions.

Companion Animal Vaccine by Segment

The study includes a forecast for the global companion animal vaccine by product type, species type, end use, and region.

Companion Animal Vaccine Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Attenuated Live
• Conjugate
• Inactivated
• Subunit
• Toxoid
• DNA
• Recombinant

Companion Animal Vaccine Market by Species Type [Shipment Analysis by Value from 2018 to 2030]:

• Canine
• Avian
• Feline
• Equine

Companion Animal Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Research Institutes
• Others

Companion Animal Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Companion Animal Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies companion animal vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the companion animal vaccine companies profiled in this report include-

• Elanco
• Boehringer Ingelheim International
• Intervet
• Zoetis Services
• Bioveta
• Sanofi
• Bayer
• Heska
• Virbac
• Hester Biosciences

Companion Animal Vaccine Market Insights

Lucintel forecasts that canine will remain the largest segment due to increasing awareness of the importance of this vaccination among dog owners for protecting their pets from serious diseases.

Within this market, hospital & clinic is expected to witness highest growth over the forecast period.

North America will remain the largest region due to high pet ownership rates and increasing awareness of the importance of pet vaccination among population in the region.

Features of the Global Companion Animal Vaccine Market

Market Size Estimates: Companion animal vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Companion animal vaccine market size by product type, species type, end use, and region in terms of value ($B).

Regional Analysis: Companion animal vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, species types, end uses, and regions for the companion animal vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the companion animal vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the companion animal vaccine market size?

Answer: The global companion animal vaccine market is expected to reach an estimated $4.8 billion by 2030.

Q.2 What is the growth forecast for companion animal vaccine market?

Answer: The global companion animal vaccine market is expected to grow with a CAGR of 6.3% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the companion animal vaccine market?

Answer: The major drivers for this market are rising awareness about importance of pet vaccination, growing cases of zoonotic diseases, and increasing interest for pet ownership in the world.

Q4. What are the major segments for companion animal vaccine market?

Answer: The future of the companion animal vaccine market looks promising with opportunities in the hospital & clinic and research institute markets.

Q5. Who are the key companion animal vaccine market companies?

Answer: Some of the key companion animal vaccine companies are as follows:

• Elanco
• Boehringer Ingelheim International
• Intervet
• Zoetis Services
• Bioveta
• Sanofi
• Bayer
• Heska
• Virbac
• Hester Biosciences

Q6. Which companion animal vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that canine will remain the largest segment due to increasing awareness of the importance of this vaccination among dog owners for protecting their pets from serious diseases.

Q7. In companion animal vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to high pet ownership rates and increasing awareness of the importance of pet vaccination among population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the companion animal vaccine market by product type (attenuated live, conjugate, inactivated, subunit, toxoid, DNA, and recombinant), species type (canine, avian, feline, and equine), end use (hospitals & clinics, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?